| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.024 | 0.6 |